Delivery Order SPE2DB24D2010-SPE2DB25FABDB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,259.50 to AmerisourceBergen Drug Corp for the supply of Scemblix 40 mg tablets (60-count units) on August 7, 2025, with an ultimate completion date of August 28, 2025. The contract utilizes firm fixed price terms and was awarded through open competition with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, performed as the prime contractor for this pharmaceutical delivery. This delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for SCEMBLIX 40 mg tablets in a quantity of 60 units. The contract, issued on August 20, 2025, carries a ceiling value of $13,259.50 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 11, 2025. This award was made without a set-aside designation, indicating it was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $13,259.50 to AmerisourceBergen Drug Corp for 60 units of Scemblix 40 mg tablets, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single transaction under the company's larger pharmaceutical supply relationship with the federal government. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major...
- The Defense Logistics Agency awarded a $13,259.50 delivery order to AmerisourceBergen Drug Corp for Scemblix 40 mg tablets (60-count units) on August 8, 2025, with an ultimate completion date of August 29, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,637.88 to AmerisourceBergen Drug Corp for the supply of Scemblix 20 mg tablets (60-count units) under a firm fixed-price contract type. The award, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. Performance will take place at the vendor's corporate...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $12,152.07. The contract is for the supply of the specialty medication Scemblix 40 mg tablets, with a period of performance through December 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC covers a wide range of...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $53,038 on August 20, 2025, for the supply of SCEMBLIX 40 mg tablets (60-count units) under a firm fixed-price contract with no set-aside designation. The order, which carries an ultimate completion date of September 11, 2025, is funded through the Defense Logistics Agency's Medical Supply Chain and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SCEMBLIX 40 MG TABLET in quantities of 60s, with a firm fixed price of $13,259.50 and a completion date of June 6, 2025. The contract is not set aside and is part of Amerisourcebergen Drug Corp's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of SCEMBLIX 40 mg tablets in quantities of 60 units, valued at $13,259.50. This non-competitive, firm fixed-price delivery order was awarded on July 31, 2025, with an ultimate completion date of August 21, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $26,519.00 for SCEMBLIX 40 mg tablets (60-count units) on August 12, 2025, with completion scheduled for September 3, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FABDBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Scemblix (asciminib) 40 mg tablets in quantities of 60 units. This $26,519 firm fixed-price delivery order represents a non-competitive award under an existing indefinite delivery contract and is scheduled for completion by September 30, 2025. Scemblix is a tyrosine kinase inhibitor used in the treatment of chronic myeloid leukemia, reflecting the federal government's continued procurement of specialized oncology medications through the Defense Logistics Agency's medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad portfolio of brand-name and generic medications, vaccines, and medical devices to support military healthcare systems and other federal medical programs globally. As a major pharmaceutical distributor based in Conshohocken, Pennsylvania, AmerisourceBergen demonstrates significant capacity to fulfill federal medical procurement requirements across multiple therapeutic domains and serves as a critical vendor for Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.5k | 9/9/25 |